Acelyrin, Inc. Profile Avatar - Palmy Investing

Acelyrin, Inc.

Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep, a small protein therapeutic designed to…

Biotechnology
US, Agoura Hills [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of SLRN's Analysis
CIK: 1962918 CUSIP: 00445A100 ISIN: US00445A1007 LEI: - UEI: -
Secondary Listings
SLRN has no secondary listings inside our databases.